dc.contributor.author | Lewis, Caroline A | |
dc.contributor.author | Muir, Alexander | |
dc.contributor.author | Danai, Laura V | |
dc.contributor.author | Gui, Dan Yi | |
dc.contributor.author | Waingarten, Chiara Y. | |
dc.contributor.author | Vander Heiden, Matthew G. | |
dc.date.accessioned | 2018-02-12T15:55:40Z | |
dc.date.available | 2018-02-12T15:55:40Z | |
dc.date.issued | 2017-08 | |
dc.date.submitted | 2017-04 | |
dc.identifier.issn | 2050-084X | |
dc.identifier.uri | http://hdl.handle.net/1721.1/113571 | |
dc.description.abstract | Many mammalian cancer cell lines depend on glutamine as a major tri-carboxylic acid (TCA) cycle anaplerotic substrate to support proliferation. However, some cell lines that depend on glutamine anaplerosis in culture rely less on glutamine catabolism to proliferate in vivo. We sought to understand the environmental differences that cause differential dependence on glutamine for anaplerosis. We find that cells cultured in adult bovine serum, which better reflects nutrients available to cells in vivo, exhibit decreased glutamine catabolism and reduced reliance on glutamine anaplerosis compared to cells cultured in standard tissue culture conditions. We find that levels of a single nutrient, cystine, accounts for the differential dependence on glutamine in these different environmental contexts. Further, we show that cystine levels dictate glutamine dependence via the cystine/glutamate antiporter xCT/SLC7A11. Thus, xCT/SLC7A11 expression, in conjunction with environmental cystine, is necessary and sufficient to increase glutamine catabolism, defining important determinants of glutamine anaplerosis and glutaminase dependence in cancer. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant R01CA168653) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant R01CA201276) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant P30CA1405141) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Award F32CA213810) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Award F32CA210421) | en_US |
dc.publisher | eLife Sciences Publications, Ltd | en_US |
dc.relation.isversionof | http://dx.doi.org/10.7554/eLife.27713 | en_US |
dc.rights | Creative Commons Attribution 4.0 International License | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | eLife | en_US |
dc.title | Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Muir, Alexander et al. “Environmental Cystine Drives Glutamine Anaplerosis and Sensitizes Cancer Cells to Glutaminase Inhibition.” eLife 2017, 6 (August 2017): e27713 © Muir et al | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.mitauthor | Muir, Alexander | |
dc.contributor.mitauthor | Danai, Laura V | |
dc.contributor.mitauthor | Gui, Dan Yi | |
dc.contributor.mitauthor | Waingarten, Chiara Y. | |
dc.contributor.mitauthor | Vander Heiden, Matthew G. | |
dc.relation.journal | eLife | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2018-02-02T18:54:20Z | |
dspace.orderedauthors | Muir, Alexander; Danai, Laura V; Gui, Dan Y; Waingarten, Chiara Y; Lewis, Caroline A; Vander Heiden, Matthew G | en_US |
dspace.embargo.terms | N | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-8206-8003 | |
dc.identifier.orcid | https://orcid.org/0000-0003-0130-3428 | |
dc.identifier.orcid | https://orcid.org/0000-0002-6702-4192 | |
mit.license | PUBLISHER_POLICY | en_US |